HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Riha, R. L. Articles by Douglas, N. J. Search for Related Content PubMed PubMed Citation Articles by Riha, R. L. Articles by Douglas, N. J.

Tumour necrosis factor- (–308) gene polymorphism in obstructive sleep apnoea–hypopnoea syndrome

¹ Respiratory Medicine, and ³ Public Health Sciences, University of Edinburgh, and ² Genetics Core, Wellcome Trust Clinical Research Facility, Edinburgh, UK.

CORRESPONDENCE: R. L. Riha, Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK. Fax: 44 1312421776. E-mail: rlriha{at}hotmail.com

Keywords: Genetics, obstructive sleep apnoea, tumour necrosis factor-

Received: November 15, 2004
Accepted July 1, 2005

Patients with obstructive sleep apnoea–hypopnoea syndrome (OSAHS) have elevated circulating levels of tumour necrosis factor (TNF)-. The hypothesis in this study was that OSAHS might be associated with the TNF- (–308A) gene polymorphism, which results in increased TNF- production. This hypothesis was examined in OSAHS patients, their siblings and population controls.

A total of 206 subjects were recruited. All underwent sleep studies and clinical review, and were subsequently classified as having OSAHS or not depending on apnoea–hypopnoea frequency, sex, age and symptoms. All subjects had blood collected and genotyping was performed on DNA extracted from peripheral leukocytes. Some 192 random UK blood donors were used as population controls.

The results demonstrated a significant association for TNF- (–308A) allele carriage with OSAHS (OR = 1.8; 95% Confidence interval: 1.18–2.75) when compared with population controls. Siblings with OSAHS were significantly more likely to carry the TNF- (–308A) allele. In addition, 21 pairs of male siblings discordant for carriage of the –308A allele showed a significant level of discordance for the OSAHS phenotype.

In conclusion, this study demonstrates an association of tumour necrosis factor- (–308A) carriage with obstructive sleep apnoea–hypopnoea syndrome, suggesting that inflammation may be implicated in the pathogenesis of this condition.

This article has been cited by other articles:

				E. Tasali and M. S. M. Ip Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation Proceedings of the ATS, February 15, 2008; 5(2): 207 - 217. [Abstract] [Full Text] [PDF]

				D. Gozal and L. Kheirandish-Gozal Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 369 - 375. [Abstract] [Full Text] [PDF]

				G. Parati, C. Lombardi, and K. Narkiewicz Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1671 - R1683. [Abstract] [Full Text] [PDF]

				G. Cavadini, S. Petrzilka, P. Kohler, C. Jud, I. Tobler, T. Birchler, and A. Fontana From the Cover: TNF-{alpha} suppresses the expression of clock genes by interfering with E-box-mediated transcription PNAS, July 31, 2007; 104(31): 12843 - 12848. [Abstract] [Full Text] [PDF]

				W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26 Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Eur. Respir. J., January 1, 2007; 29(1): 156 - 178. [Abstract] [Full Text] [PDF]